Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 24;12(2):169.
doi: 10.3390/life12020169.

Serum Adropin Levels in Patients with Rheumatoid Arthritis

Affiliations

Serum Adropin Levels in Patients with Rheumatoid Arthritis

Petra Simac et al. Life (Basel). .

Abstract

Adropin is a secretory protein that mainly modulates metabolic homeostasis and endothelial function. There is growing evidence supporting association of adropin with various inflammatory diseases, including rheumatoid arthritis (RA). This study aimed to compare serum adropin levels between 70 patients with RA and 70 matched healthy controls. Furthermore, we explored adropin correlations with RA disease activity, glucose metabolism parameters and inflammatory biomarkers. Serum adropin levels were determined by a competitive enzyme-linked immunosorbent assay. Serum adropin levels were significantly lower in RA patients than in the control group (2.85 ± 0.91 vs. 4.02 ± 0.99 ng/mL, p < 0.001). In the RA group, serum adropin levels had a significant negative correlation with total cholesterol (r = -0.172, p = 0.043), HbA1c (r = -0.406, p < 0.001), fasting glucose (r = -0.377, p < 0.001) and HOMA-IR (the homeostasis model assessment-estimated insulin resistance; (r = -0.315, p = 0.008)). Multiple linear regression analysis showed that serum adropin levels retained a significant association with levels of fasting glucose (β ± SE, -0.450 ± 0.140, p = 0.002) and HbA1c (-0.528 ± 0.223, p = 0.021) after model adjustments. These findings imply that adropin could have an impact on metabolic homeostasis in RA, although further well-designed studies are warranted in order to establish this.

Keywords: adropin; inflammatory disease; metabolic homeostasis; rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of serum adropin levels between the control group (n = 70) and the RA group (n = 70). The data are presented as the mean ± standard deviation. * t-test for independent samples (p < 0.001).
Figure 2
Figure 2
Correlation analysis of adropin levels with HbA1c (A), HOMA-IR (B), fasting insulin (C) and fasting glucose (D) in RA group. Red lines represent the regression line, while green lines represent 95% confidence interval. * Pearson’s correlation coefficient.
Figure 3
Figure 3
Correlation between serum adropin levels and (A) HAQ and (B) DAS28 score (n = 70). Red lines represent the regression line, while green lines represent 95% confidence interval. * Spearman’s correlation coefficient.

References

    1. Alamanos Y., Voulgari P.V., Drosos A.A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review. Semin. Arthritis Rheum. 2006;36:182–188. doi: 10.1016/j.semarthrit.2006.08.006. - DOI - PubMed
    1. López-Mejías R., Castañeda S., González-Juanatey C., Corrales A., Ferraz-Amaro I., Genre F., Remuzgo-Martínez S., Rodriguez-Rodriguez L., Blanco R., Llorca J., et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. Autoimmun. Rev. 2016;15:1013–1030. doi: 10.1016/j.autrev.2016.07.026. - DOI - PubMed
    1. Baghdadi L.R., Woodman R.J., Shanahan E.M., Mangoni A.A. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: A systematic review and metaanalysis. PLoS ONE. 2015;17:e0117952. doi: 10.1371/journal.pone.0117952. - DOI - PMC - PubMed
    1. Crepaldi G., Scirè C.A., Carrara G., Sakellariou G., Caporali R., Hmamouchi I., Dougados M., Montecucco C. Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis. PLoS ONE. 2016;11:e0146991. doi: 10.1371/journal.pone.0146991. - DOI - PMC - PubMed
    1. Solomon D.H., Reed G.W., Kremer J.M., Curtis J.R., Farkouh M.E., Harrold L.R., Hochberg M.C., Tsao P., Greenberg J.D. Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol. 2015;67:1449–1455. doi: 10.1002/art.39098. - DOI - PMC - PubMed

LinkOut - more resources